Skip to main content

Advertisement

Log in

The autoimmune lymphoproliferative syndrome (Canale–Smith) in adulthood

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The autoimmune lymphoproliferative syndrome (ALPS) or Canale–Smith syndrome is a recently described clinical entity consisting of chronic, non-malignant lymphadenopathy and hepatosplenomegaly together with hypergammaglobulinemia, positive autoantibodies and/or overt autoimmune diseases. It is caused by a genetic defect in the mechanism of programmed cell death (apoptosis) and is characterized by the presence of double-negative (TCR α/β CD4− CD8−) T lymphocytes (DNT). Although well known in pediatric patients, ALPS is an unusual diagnosis in adults. The oldest reported patient was aged 54. We describe another two adult patients in whom a presenting autoimmune disease led to the diagnosis of ALPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ALPS:

Autoimmune lymphoproliferative syndrome

DNT:

Double-negative lymphocytes

References

  1. Straus SE, Sneller M, Lenardo MJ, Puck J, Strober W (1999) An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome. Ann Intern Med 130:591–601

    CAS  PubMed  Google Scholar 

  2. Drappa J, Vaishaw AK, Sullivan KE, Chu JL, Elkon KB (1996) Fas gene mutations in the Canale–Smith syndrome an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643–1649

    CAS  PubMed  Google Scholar 

  3. Sneller MC, Straus SE, Jaffe ES et al. (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334–341

    CAS  PubMed  Google Scholar 

  4. Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200

    Article  CAS  PubMed  Google Scholar 

  5. Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11:521–527

    Google Scholar 

  6. Rieux Laucat F, Blachere S, Danielan S et al. (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94:2575–2582

    CAS  PubMed  Google Scholar 

  7. Infante AJ, Britton HA, DeNapoliu T et al. (1998) The clinical spectrum in large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629–633

    CAS  PubMed  Google Scholar 

  8. Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200

    Article  CAS  PubMed  Google Scholar 

  9. Gronbaek K, Straten PT, Ralfkiaer E et al. (1998) Somatic Fas mutations in non-Hodgkin’s lymphoma: association with extranodal disease and autoimmuníty. Blood 92:3018–3024

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. P. Dourakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deutsch, M., Tsopanou, E. & Dourakis, S.P. The autoimmune lymphoproliferative syndrome (Canale–Smith) in adulthood. Clin Rheumatol 23, 43–44 (2004). https://doi.org/10.1007/s10067-003-0830-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-003-0830-2

Keywords

Navigation